Characteristics of the included trials
Trial | Patient population* | Duration and exercise mode | Type of exercise |
1. Alemo Munters et al 52, Sweden | 21 (PM/DM) | 12 weeks, cardiorespiratory | Cycling |
2. Alexanderson et al 26, Sweden | 13 (PM/DM) | 24 weeks, cardiorespiratory and strength | Walking, strength exercise programme |
3. Baillet et al 37, France | 48 (RA) | 4 weeks, cardiorespiratory and strength | Cycling, running, resisting pulley cord |
4. Baslund et al 36, Denmark | 18 (RA) | 8 weeks, cardiorespiratory | Cycling |
5. Daltroy et al 34, USA | 58 (IRDs) | 12 weeks, Cardiorespiratory | Cycling |
6. de Jong et al 35 38, The Netherlands | 281 (RA) | 2 years, cardiorespiratory and strength | Cycling, strength exercise programme |
7. Durcan et al 39, Ireland | 78 (RA) | 12 weeks, cardiorespiratory and strength | Walking, strength exercise programme |
8. Flint-Wagner et al 40, USA | 22 (RA) | 16 weeks, strength | Strength exercise programme |
9. Häkkinen et al 41, Finland | 39 (RA) | 6 months, strength | Strength exercise programme |
10. Häkkinen et al 42 43, Finland | 62 (RA) | 2 years, strength | Strength exercise programme |
11. Hansen et al 31, Denmark | 75 (RA) | 2 years, cardiorespiratory | Cycling, swimming, walking, running |
12. Harkcom et al 32, USA | 17 (RA) | 12 weeks, cardiorespiratory | Cycling |
13. Hsieh et al 49, Taiwan | 19 (AS) | 3 months, cardiorespiratory and strength | Aerobics, strength exercise programme |
14. Jennings et al 50, Brazil | 70 (AS) | 12 weeks, cardiorespiratory | Walking |
15. Karapolat et al 51, Turkey | 37 (AS) | 6 weeks, cardiorespiratory | Swimming, walking |
16. Komatireddy et al 44, USA | 42 (RA) | 12 weeks, strength | Strength exercise programme |
17. Lemmey et al 45, United Kingdom | 28 (RA) | 24 weeks, strength | Strength exercise programme |
18. Melikoglu et al 46, Turkey | 36 (RA) | 2 weeks, cardiorespiratory | Walking/running (treadmill) |
19. Miossi et al 27, Brazil | 28 (SLE) | 3 months, cardiorespiratory and strength | Walking/running (treadmill), strength exercise programme |
20. Niedermann et al 28, Switzerland | 106 (AS) | 12 weeks, cardiorespiratory | Nordic walking |
21. Sandstad et al 29, Norway | 15 (RA/JIA) | 10 weeks, cardiorespiratory | Cycling |
22. Sveaas et al 30, Norway | 24 (axial SpA) | 12 weeks, cardiorespiratory and strength | Walking/running (treadmill), strength exercise programme |
23. Tench et al 33, United Kingdom | 65 (SLE) | 12 weeks, cardiorespiratory | Mainly walking (cycling, swimming) |
24. van den Ende et al 47, The Netherlands | 50 (RA) | 12 weeks, cardiorespiratory | Cycling, walking, knee bending, step-ups, high pace strength exercises |
25. Westby et al 48, Canada | 21 (RA) | 12 months, cardiorespiratory and strength | Aerobic dance, strength exercise programme |
26. Wiesinger et al 53, Austria | 13 (PM/DM) | 6 months, cardiorespiratory | Cycling, step aerobics |
*Number of patients included in the results.
AS, ankylosing spondylitis; DM, dermatomyositis; EG, exercise group; IRDs, inflammatory rheumatic diseases; JIA, juvenile idiopathic arthritis; PM, polymyositis; RA, rheumatoid arthritis; SLE, systemic lupus erythematosus; SpA, spondyloarthritis.